Anna Mukhinа

899 citations

23 papers · 21 indexed · h-index 3

Co-authors: Anna Shcherbina Yulia Rodina Anna Roppelt Dmitry Pershin Alexandra Laberko Lyubov E. Salnikova Joris M. van Montfrans О. П. Рыжкова
Topics: Immunodeficiency and Autoimmune Disorders (18 papers)Blood disorders and treatments (6 papers)Pediatric health and respiratory diseases (3 papers)
Cited by: Genetics Immunology Hematology
Journals: SHILAP Revista de lepidopterologíaInternational Journal of Molecular Sciences Journal of Allergy and Clinical Immunology
Partner nations: Russia United States Austria

In The Last Decade

Anna Mukhinа

10 papers receiving 21 citations

Peers

Countries citing papers authored by Anna Mukhinа

Since Specialization

Citations

This map shows the geographic impact of Anna Mukhinа's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Mukhinа with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Mukhinа more than expected).

Fields of papers citing papers by Anna Mukhinа

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Mukhinа. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Mukhinа. The network helps show where Anna Mukhinа may publish in the future.

Co-authorship network of co-authors of Anna Mukhinа

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Mukhinа. A scholar is included among the top collaborators of Anna Mukhinа based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Mukhinа. Anna Mukhinа is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	13q Deletion Syndrome Presenting with Lymphopenia Detected Through Newborn Screening for Primary Immunodeficiencies 2025 ·International Journal of Molecular Sciences ·(unknown),Anna Mukhinа,(unknown),(unknown),(unknown),Dmitry Pershin,(unknown),(unknown),Dmitry Meleshko,Р. А. Зинченко,(unknown),(unknown),Anna Shcherbina,Sergey I. Kutsev,Andrey V. Marakhonov	0
2	Epidemiology and management of malignancies in patients with inborn errors of immunity—An ESID registry study of 19,959 patients 2025 ·Journal of Allergy and Clinical Immunology ·(unknown),(unknown),Andishe Attarbaschi,(unknown),Klaus Warnatz,Georgia Mueller,Anna Mukhinа,Stephan Rusch,(unknown),Joris M. van Montfrans,(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown)	0
3	Harmonizing TREC Thresholds in Newborn Screening for SCID: Insights From Russian Validation Cohort 2025 ·Journal of Clinical Laboratory Analysis ·Andrey V. Marakhonov,(unknown),Sergey S. Larin,(unknown),(unknown),Anna Mukhinа,Yulia Rodina,(unknown),(unknown),(unknown),(unknown),Р. А. Зинченко,(unknown),Anna Shcherbina,Sergey I. Kutsev	0
4	Advanced neonatal screening for hereditary diseases in Russia: first results and future prospects 2024 ·PEDIATRIA Journal named after G N SPERANSKY ·(unknown),Ekaterina Zakharova,Galina Baydakova,Andrey V. Marakhonov,(unknown),О. П. Рыжкова,(unknown),A. G. Rumyantsev,Anna Shcherbina,Anna Mukhinа,(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),Sergey I. Kutsev	5
5	Genetic Characteristics of a Large Pediatric Cohort of Patients with Inborn Errors of Immunity: Single-Center Experience 2024 ·Journal of Clinical Immunology ·(unknown),(unknown),Anna Mukhinа,Yulia Rodina,(unknown),Dmitry Pershin,(unknown),(unknown),(unknown),Галина Новичкова,Anna Shcherbina	1
6	Allogeneic Hematopoietic Stem Cell Transplantation Activity in Inborn Errors of Immunity in Russian Federation 2023 ·Journal of Clinical Immunology ·Alexandra Laberko,Anna Mukhinа,(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),Е. В. Скоробогатова,Irina Kondratenko,(unknown),Anna Shcherbina,L. S. Zubarovskaya,Dmitry Balashov,(unknown)	1
7	NEONATAL SCREENING, POSTNATAL DIAGNOSIS AND TACTICS OF PRECLINICAL TREATMENT AND PREVENTION OF PRIMARY IMMUNODEFICIENCIES IN CHILDREN. GUIDELINES BY THE EXPERTS FROM THE NATIONAL ASSOCIATION OF EXPERTS IN PRIMARY IMMUNODEFICIENCIES (NAEPID) AND THE ASSOCIATION OF MEDICAL GENETICS (AMG) OF RUSSIA 2023 ·PEDIATRIA Journal named after G N SPERANSKY ·(unknown),Р. А. Зинченко,(unknown),Sergey I. Kutsev,Andrey V. Marakhonov,Anna Mukhinа,G. А. Novichkova,Dmitry Pershin,(unknown),A. G. Rumyantsev,Anna Shcherbina	0
8	Treatment of lymphoid malignancies in patients with primary immunodeficiencies associated with DNA repair defects 2023 ·Pediatric Hematology/Oncology and Immunopathology ·(unknown),(unknown),Anna Mukhinа,(unknown),Д. С. Абрамов,(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),Anna Shcherbina,Elena Deripapa,(unknown)	1
9	An autoinflammatory disease – PFAPA syndrome: a single-center experience 2022 ·Pediatric Hematology/Oncology and Immunopathology ·(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),Anna Mukhinа,(unknown),G. А. Novichkova,Anna Shcherbina	0
10	A case report of autoinflammation and PLCy2-associated antibody deficiency and immune dysregulation 2022 ·Pediatric Hematology/Oncology and Immunopathology ·(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),Anna Mukhinа,Irina Mersiyanova,(unknown),(unknown)	0
11	Newborn screening for primary immunodeficiencies as a way to detect syndromal disorders in neonates: a clinical case of 22q11.2DS syndrome 2022 ·Pediatric Hematology/Oncology and Immunopathology ·(unknown),Anna Mukhinа,(unknown),(unknown),Dmitry Pershin,(unknown),Andrey V. Marakhonov,(unknown),Р. А. Зинченко,Anna Shcherbina,Sergey I. Kutsev	2
12	BCG Infection in Patients With Inborn Errors of Immunity Receiving the Russian BCG Strain 2022 ·The Journal of Allergy and Clinical Immunology In Practice ·Alexandra Laberko,(unknown),(unknown),Anna Roppelt,Anna Mukhinа,Yulia Rodina,Dmitry Pershin,Aristine Cheng,Michail S. Lionakis,(unknown),(unknown),(unknown),Галина Новичкова,Anna Shcherbina	4
13	Clinical case of type I interferonopathy: homozygous STAT2 gain-of-function mutation 2021 ·Pediatric Hematology/Oncology and Immunopathology ·(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),Anna Roppelt,(unknown),(unknown),(unknown),(unknown),(unknown),Anna Mukhinа,(unknown),Д. С. Абрамов,(unknown),Д. М. Коновалов,G. А. Novichkova	0
14	Evans syndrome in children: the results of a retrospective study of 54 patients 2021 ·Pediatric Hematology/Oncology and Immunopathology ·(unknown),(unknown),(unknown),Anna Pavlova,(unknown),Irina Mersiyanova,(unknown),(unknown),Anna Mukhinа,(unknown),Anna Shcherbina,Alexey Maschan,Н.С. Сметанина	0
15	Rituximab and Abatacept Are Effective in Differential Treatment of Interstitial Lymphocytic Lung Disease in Children With Primary Immunodeficiencies 2021 ·Frontiers in Immunology ·Yulia Rodina,Elena Deripapa,(unknown),Anna Mukhinа,Anna Roppelt,(unknown),Alexandra Laberko,(unknown),Д. С. Абрамов,(unknown),G. А. Novichkova,Anna Shcherbina	3
16	A rare case of combined immunodeficiency due to a deletion of 11(q) – Jacobsen syndrome 2020 ·Pediatric Hematology/Oncology and Immunopathology ·(unknown),(unknown),Anna Mukhinа	0
17	Genetic and Clinical Features of Shwachman-Diamond Syndrome in Russian Population: Prospective Study 2020 ·SHILAP Revista de lepidopterología ·(unknown),(unknown),(unknown),Anna Mukhinа,(unknown),(unknown),(unknown),Anna Pavlova,(unknown),(unknown),(unknown),Anna Shcherbina	2
18	EXPERIENCE OF PRENATAL DIAGNOSIS OF PRIMARY IMMUNODEFICIENCY STATES 2019 ·PEDIATRIA Journal named after G N SPERANSKY ·(unknown),(unknown),Anna Mukhinа,(unknown),(unknown),G. А. Novichkova,Anna Shcherbina	1
19	Zoya Kosmodemyanskaya – Grunja Friedrich – Christina Orletsova: transformation of the Soviet myth in the drama and in the novel of Boris Pasternak 2019 ·Anna Mukhinа	1
20	Register of primary immunodeficiency in the Stavropol territory 2019 ·Medical news of the North Caucasus ·(unknown),(unknown),(unknown),(unknown),Anna Mukhinа	0

About Anna Mukhinа

Anna Mukhinа is a scholar working on Immunology, General Social Sciences and Emergency Medical Services, having authored 23 papers that have together received 21 indexed citations. Recurring topics across this work include Immunodeficiency and Autoimmune Disorders (18 papers), Blood disorders and treatments (6 papers) and Pediatric health and respiratory diseases (3 papers). The work is most often cited by research in Genetics (7 citations), Immunology (12 citations) and Hematology (3 citations). Anna Mukhinа has collaborated with scholars based in Russia, United States and Austria. Frequent co-authors include Anna Shcherbina, Yulia Rodina, Anna Roppelt, Dmitry Pershin, Alexandra Laberko, Lyubov E. Salnikova, Joris M. van Montfrans, О. П. Рыжкова, Alexey Maschan and Andishe Attarbaschi. Their work appears in journals such as SHILAP Revista de lepidopterología, International Journal of Molecular Sciences and Journal of Allergy and Clinical Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact